Article Sidebar
Views pdf: 67
ALBUMIN-BILIRUBIN (ALBI) AND PLATELET-ALBUMIN-BILIRUBIN (PALBI) GRADES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS AT THAI NGUYEN NATIONAL HOSPITAL
Main Article Content
Abstract
Objectives: To analyze of the relationship between ALBI, PALBI grades and some clinical and subclinical characteristics in patients with hepatocellular carcinoma (HCC) with cirrhosis at Thai Nguyen National Hospital. Materials and methods: A cross-sectional study of 112 patients with HCC with cirrhosis at Thai Nguyen National Hospital from May 2022 to August 2024. Results: A total of 112 patients were studied. The majority were males ( 76.8%), average age were 52.3±10.4 (year old). History of hepatitis B was 59.8%. The rate of Child-pugh A, B, C were: 67%, 22.3% and 10.7%, respectively. The rate of ALBI of grades 1,2,3 were 31.3%, 58.9% and 9.8% respectively; The rate of PALBI of grades 1,2,3 were 36.6%, 38.4% and 25.0% respectively. Conclussions: ALBI grades increased gradually with plasma AFP concentration and tumor number. There was no significant difference in ALBI grades with tumor size.
Article Details
Keywords
ALBI, PALBI, Child Pugh, hepatocellular carcinoma
References
2. Nguyễn Công Long, Đàm Thị Phương (2022), Khảo sát các chỉ số Albumin-Bilirubin ở bệnh nhân xơ gan có ung thư biểu mô tế bào gan, Tạp chí Y học Việt nam, Tập 510, số 1, trang 53-56.
3. Lê Hoài Thương, Trần Ngọc Ánh, Đậu Quang Liêu (2021), Một số đặc điểm dịch tễ, lâm sàng, cận lâm sàng của bệnh nhân ung thư biểu mô tế bào gan tạo bệnh viện Đại học Y Hà Nội, Tạp chí Nghiên cứu Y học, số 147 (11), trang 92-100.
4. Nguyễn Huy Toàn, Trần Huy Kính, Hồ Duy Tuấn Anh (2022), Giá trị của phân độ ALBI, PALBI trong đánh giá chức năng gan ở bệnh nhân ung thư biểu mô tế bào gan có xơ gan tại Bệnh viện hữu nghị đa khoa Nghệ An, Tạp chí Y Dược học - Trường Đại học Y Dược Huế - Số 5, tập 12, trang 115-120.
5. Chen PH, Hsieh WY, Su CW, Hou MC, Wang YP, Hsin IF, et al (2018), Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices. Gastrointest Endosc. 88 (2): 230-239.e2.
6. Mohammadi, H., Abuodeh, Y., Jin, W., Frakes, J., Friedman, M., Biebel, B., Hoffe, S. (2018), Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma. Journal of Gastrointestinal Oncology, 9 (5), 840 - 840.
7. Oikonomou T, Goulis I, Doumtsis P, Tzoumari T, Akriviadis E, Cholongitas E (2019), ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis, Ann Hepatol, 18 (1): 126-136
8. Wang Z, Fan Q, Wang M, Wang E, Li H, Liu L (2020), Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma, Ann Transl Med; 8 (8): 537. doi: 10.21037/atm.2020.02.114.
